Share this article
Share this article
NEW YORK, Feb. 22, 2021 /PRNewswire/ BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its participation in the NY Forward Rapid Testing Program and opened eight locations offering COVID-19 rapid testing around New York. This program is designed to provide New Yorkers, and those visiting, with inexpensive and rapid COVID-19 testing.
NY Forward is a collaboration with The Empire State Development Corporation, The Real Estate Board of New York (REBNY), the City s leading real estate trade association, CVS Pharmacy, and BioReference to offer rapid COVID-19 specimen collection and testing at locations throughout New York. In the coming weeks, several hundred additional testing locations will open throughout the State.
New York State Partners with BioReference Laboratories to Spearhead the NY Forward COVID-19 Rapid Test Program to Help Reopen the New York Economy troyrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from troyrecord.com Daily Mail and Mail on Sunday newspapers.